Loading insider details...
Latest Form 4 (Jun 17, 2026): Grant/Award of 150,000 ZBIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 17, 2026 | Zenas BioPharma, Inc. (ZBIO) | Grant/Award | 150,000 | n/a |
| Apr 17, 2025 | Zenas BioPharma, Inc. (ZBIO) | Grant/Award | 400,000 | n/a |
| Feb 20, 2025 | Seres Therapeutics, Inc. (MCRB) | Exercise/Conversion | 2,969 | n/a |
| Feb 11, 2025 | Seres Therapeutics, Inc. (MCRB) | Grant/Award | 650,000 | n/a |
| Nov 19, 2024 | Seres Therapeutics, Inc. (MCRB) | Exercise/Conversion | 2,969 | n/a |
| Oct 29, 2024 | Seres Therapeutics, Inc. (MCRB) | Exercise/Conversion | 13,744 | n/a |
| Aug 19, 2024 | Seres Therapeutics, Inc. (MCRB) | Exercise/Conversion | 2,969 | n/a |
| Jun 6, 2024 | Cara Therapeutics, Inc. (CARA) | Grant/Award | 150,647 | n/a |
| May 18, 2024 | Seres Therapeutics, Inc. (MCRB) | Exercise/Conversion | 2,968 | n/a |
| Feb 17, 2024 | Seres Therapeutics, Inc. (MCRB) | Exercise/Conversion | 11,875 | n/a |